Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 6, Issue 4, Pages 285-287
http://dx.doi.org/10.1080/09629359791631

(1→3)-β-D-glucan in patients with pulmonary aspergilloma

Department of Pulmonary Disease, Tokyo Metropolitan Komagome General Hospital, 3-18-22 Honkomagome, Bunkyou-ku, Tokyo 113, Japan

Copyright © 1997 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

To elucidate the role of (1→3)-β-D-glucan in pulmonary aspergilloma, serum concentrations of (1→3)-β-D-glucan were measured repeatedly for as long as 10 months in eight patients. In four patients with inactive disease, concentrations of (1→3)-β-D-glucan were in the normal range.The concentrations of (1→3)-β-D-glucan increased in two patients, although the disease was inactive. This increase might show the earliest stage of the invasive process of the disease. In two other patients with active disease, (1→3)-β-D-glucan increased. Other parameters, such as galactomannan, immunodiffusion and a radio-allergosorbent test, as well as inflammatory m arkers such as C-reactive protein and the leukocyte count, did not show any consistent tendency in regard to the activity of the disease. Thus, a (1→3)-β-D-glucan assay may add valuable data for evaluating the disease activity and understanding the disease process of pulmonary aspergilloma.